Relationship between extracellular 5-hydroxytryptamine and behaviour following monoamine oxidase inhibition and L-tryptophan
- PMID: 2451963
- PMCID: PMC1853803
- DOI: 10.1111/j.1476-5381.1988.tb11435.x
Relationship between extracellular 5-hydroxytryptamine and behaviour following monoamine oxidase inhibition and L-tryptophan
Abstract
1. The present study investigates the effects of selective and a non-selective monoamine oxidase (MAO) inhibitors combined with L-tryptophan on MAO-A and -B activity, hypothalamic extracellular 5-hydroxytryptamine (5-HT) in vivo and the occurrence of the 5-HT behavioural syndrome. 2. Selective inhibition of intraneuronal MAO-A with MDL 72394 (0.5 mg kg-1, i.p.) had no effect on extracellular 5-HT and following administration of L-tryptophan (50 mg kg-1, i.p.) the 5-HT behavioural syndrome was not induced. 3. Selective inhibition of MAO-A at all sites with clorgyline (5 mg kg-1, i.p.) increased extracellular 5-HT but did not induce the 5-HT behavioural syndrome when combined with L-tryptophan administration. 4. Selective inhibition of MAO-B with selegiline (10 mg kg-1, i.p.) had no effect on extracellular 5-HT and the 5-HT behavioural syndrome was not observed after L-tryptophan administration. 5. Inhibition of MAO-A and -B with a higher and therefore non-selective, dose of MDL 72394 (2 mg kg-1) markedly increased extracellular 5-HT but failed to induce the 5-HT behavioural syndrome after L-tryptophan administration. 6. Inhibition of MAO-A and -B at all sites in the brain (tranylcypromine 20 mg kg-1, i.p. or clorgyline 5 mg kg-1 plus selegiline 10 mg kg-1) increased extracellular 5-HT and induced the behavioural syndrome on administration of L-tryptophan. 7. The results demonstrate that inhibition of MAO-A and -B both within amine neurones and elsewhere in the brain is essential for the development of the 5-HT behavioural syndrome. Whilst the syndrome is associated with increased extracellular 5-HT this does not appear necessarily to result in the syndrome and may indicate that increased extracellular 5-HT is not solely involved in the induction of the '5-HT behavioural syndrome'. Whilst the syndrome is associated with increased extracellular 5-HT this does not appear necessarily to result in the syndrome and may indicate that increased extracellular 5-HT is not solely involved in the induction of the '5-HT behavioural syndrome'.
Similar articles
-
Behavioural hyperactivity in rats treated with selective monoamine oxidase inhibitors and LM 5008, a selective 5-hydroxytryptamine uptake blocker.Br J Pharmacol. 1983 Jul;79(3):765-70. doi: 10.1111/j.1476-5381.1983.tb10015.x. Br J Pharmacol. 1983. PMID: 6418248 Free PMC article.
-
Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.Br J Pharmacol. 1975 Nov;55(3):415-22. doi: 10.1111/j.1476-5381.1975.tb06946.x. Br J Pharmacol. 1975. PMID: 1203627 Free PMC article.
-
Increased total activity in the rat after L-tryptophan plus the monoamine oxidase-A inhibitor amiflamine but not after L-tryptophan plus clorgyline.Br J Pharmacol. 1985 Jul;85(3):581-90. doi: 10.1111/j.1476-5381.1985.tb10552.x. Br J Pharmacol. 1985. PMID: 2411326 Free PMC article.
-
[A behavioral and neurochemical study on the mechanism of the anxiolytic effect of monoamine oxidase inhibitors].Hokkaido Igaku Zasshi. 2001 May;76(3):133-42. Hokkaido Igaku Zasshi. 2001. PMID: 11481866 Review. Japanese.
-
Selective MAO A and B inhibitors: their mechanism of action and pharmacology.Neuropharmacology. 1983 Mar;22(3 Spec No):441-6. doi: 10.1016/0028-3908(83)90194-6. Neuropharmacology. 1983. PMID: 6304562 Review.
Cited by
-
Concurrent determination of effects of p-chloroamphetamine on central extracellular 5-hydroxytryptamine concentration and behaviour.Br J Pharmacol. 1989 Apr;96(4):801-6. doi: 10.1111/j.1476-5381.1989.tb11887.x. Br J Pharmacol. 1989. PMID: 2472844 Free PMC article.
-
Modulation by drugs of the release of total tritium and 3H-5-HT from rat hypothalamic slices.Naunyn Schmiedebergs Arch Pharmacol. 1990 May;341(5):398-403. doi: 10.1007/BF00176330. Naunyn Schmiedebergs Arch Pharmacol. 1990. PMID: 2366876
-
Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat.Naunyn Schmiedebergs Arch Pharmacol. 1993 Jun;347(6):583-90. doi: 10.1007/BF00166940. Naunyn Schmiedebergs Arch Pharmacol. 1993. PMID: 7689703
-
Proceedings of the British Pharmacological Society Meeting. 3rd-5th January 1990. Abstracts.Br J Pharmacol. 1990 Apr;99 Suppl(Suppl):1P-302P. Br J Pharmacol. 1990. PMID: 2317620 Free PMC article. No abstract available.
-
Differential behavioral syndrome evoked in the rats after multiple doses of SSRI fluoxetine with selective MAO inhibitors rasagiline or selegiline.J Neural Transm (Vienna). 2008;115(1):107-16. doi: 10.1007/s00702-007-0811-8. Epub 2007 Sep 7. J Neural Transm (Vienna). 2008. PMID: 17823767
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources